hepatitis C virus (HCV) FibroSURE

Indications

• assessment of Liver status following a diagnosis of hepatitis C virus (HCV)
• baseline determination of liver status before initiating hepatitis C virus (HCV) therapy
• post-treatment assessment of liver status six months after completion of hepatitis C virus (HCV) therapy
• non-invasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy

Procedure

• alpha-2-Macroglobulin in serum
• haptoglobin in serum
• apolipoprotein A1 in serum
• bilirubin total in serum
• gamma-glutamyltransferase in serum
• alanine aminotransferase in serum

Interpretation

• a fibrosis score is calculated

More general terms

• liver (function) tests (LFT, liver panel, hepatic function panel)